Weight Loss of Over 100 lbs in a Patient of Prader-Willi Syndrome Treated With Glucagon-Like Peptide-1 (GLP-1) Agonists

Prader-Willi syndrome (PWS) is the most common genetic obesity syndrome. The clinical features of this condition include childhood obesity, hyperphagia, infantile hypotonia, hypogonadism, short stature, and characteristic facial features. The leading cause of morbidity and mortality in PWS is hyperp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Sana, Naz, Arooj, K, Mahnoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024922/
https://www.ncbi.nlm.nih.gov/pubmed/36945294
http://dx.doi.org/10.7759/cureus.35102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024922/
https://www.ncbi.nlm.nih.gov/pubmed/36945294
http://dx.doi.org/10.7759/cureus.35102

Ejemplares similares